Your browser doesn't support javascript.
loading
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.
Fuchs, Charles S; Doi, Toshihiko; Jang, Raymond W; Muro, Kei; Satoh, Taroh; Machado, Manuela; Sun, Weijing; Jalal, Shadia I; Shah, Manish A; Metges, Jean-Phillipe; Garrido, Marcelo; Golan, Talia; Mandala, Mario; Wainberg, Zev A; Catenacci, Daniel V; Ohtsu, Atsushi; Shitara, Kohei; Geva, Ravit; Bleeker, Jonathan; Ko, Andrew H; Ku, Geoffrey; Philip, Philip; Enzinger, Peter C; Bang, Yung-Jue; Levitan, Diane; Wang, Jiangdian; Rosales, Minori; Dalal, Rita P; Yoon, Harry H.
Afiliación
  • Fuchs CS; Yale Cancer Center, New Haven, Connecticut.
  • Doi T; National Cancer Center East, Chiba, Japan.
  • Jang RW; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Muro K; University of Toronto, Toronto, Ontario, Canada.
  • Satoh T; Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
  • Machado M; Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
  • Sun W; Portuguese Institute of Oncology, Porto, Portugal.
  • Jalal SI; University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Shah MA; Now with the University of Kansas, Kansas City.
  • Metges JP; Indiana University School of Medicine, Indianapolis.
  • Garrido M; Weill Cornell Medicine, New York Presbyterian Hospital, New York.
  • Golan T; Centre Hospitalier Regional Universitaire (CHRU) de Brest-Hopital Morvan, Brest, France.
  • Mandala M; Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Wainberg ZA; The Oncology Institute at the Chaim Sheba Medical Center at Tel Hashomer, Ramat Gan, Israel.
  • Catenacci DV; The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Ohtsu A; ASST Papa Giovanni XXIII, Cancer Center, Bergamo, Italy.
  • Shitara K; David Geffen School of Medicine at University of California, Los Angeles.
  • Geva R; University of Chicago Medicine, Chicago, Illinois.
  • Bleeker J; National Cancer Center East, Chiba, Japan.
  • Ko AH; National Cancer Center East, Chiba, Japan.
  • Ku G; Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.
  • Philip P; Sanford Health, Sioux Falls, South Dakota.
  • Enzinger PC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.
  • Bang YJ; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Levitan D; Karmanos Cancer Institute, Detroit, Michigan.
  • Wang J; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Rosales M; Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Dalal RP; Merck & Co, Inc, Kenilworth, New Jersey.
  • Yoon HH; Merck & Co, Inc, Kenilworth, New Jersey.
JAMA Oncol ; 4(5): e180013, 2018 05 10.
Article en En | MEDLINE | ID: mdl-29543932
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Unión Esofagogástrica / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Unión Esofagogástrica / Anticuerpos Monoclonales Humanizados / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Oncol Año: 2018 Tipo del documento: Article